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Abstract: Apigenin (4’,5,7,-trihydroxyflavone) is a flavonoid abundant in the 
common fruits, herbs and vegetables constituting the bulk of the human diet. 
This study was aimed at quantifying the effects of apigenin on the basic cellular 
traits determining cancer development, i.e. cell proliferation, gap junctional 
coupling, and motility, using the Dunning rat prostate MAT-LyLu cell model. 
We demonstrated that apigenin considerably inhibits MAT-LyLu cell 
proliferation and significantly enhances the intensity of connexin43-mediated 
gap junctional coupling. This effect correlates with an increased abundance of 
Cx43-positive plaques at the cell-to-cell borders seen in apigenin-treated 
variants. Moreover, we observed an inhibitory effect of apigenin on the motility 
of MAT-LyLu cells. The basic parameters characterising MAT-LyLu cell 
motility, especially the rate of cell displacement, considerably decreased upon 
apigenin administration. This in vitro data indicates that apigenin may affect 
cancer development in general, and prostate carcinogenesis in particular, via its 
influence on cellular activities decisive for both cancer promotion and 
progression, including cell proliferation, gap junctional coupling and cell 
motility and invasiveness.  
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INTRODUCTION 
 
In a simplistic model of cancer development, deregulation of the signalling 
pathways determining cell proliferation and the dysfunction of gap junction 
proteins [1, 2] is often followed by the unrestricted (invasive) migration of 
cancer cells [3-5]. Neoplastic cells released from the controlling regime of the 
surrounding tissue can actively invade (intravasate) blood vessels and/or 
lymphatic vessels to reach the bloodstream and subsequently extravasate to form 
metastases by an expansive growth in the parenchyma of the target tissue [6]. 
Thus, aberrant proliferation, gap junctional coupling and cell motility seem to be 
cellular traits crucial for cancer development [7].   
In recent years, plant polyphenolic compounds like phenolic acids and 
flavonoids drew considerable attention as chemopreventive dietary agents that 
are abundantly present in common fruits, herbs and vegetables. These substances 
have been shown to exhibit cancer-preventing activities in a variety of animal 
models of carcinogenesis, including prostate cancers [8, 9]. Among them, 
apigenin (4’,5,7,-trihydroxyflavone) was shown to possess remarkable anti-
inflammatory, anti-oxidant and anti-carcinogenic properties [10]. For example, 
an inhibitory effect of apigenin on UVB-induced skin carcionogenesis in hairless 
mice was demonstrated in vivo [11], and cell cycle arrest and/or apoptosis of 
normal and tumour cells was shown to be induced by apigenin in many in vitro 
studies [7, 10, 12-17]. This flavonoid was also shown to counteract the action of 
tumour promoters on gap junctional coupling [30]. Furthermore, it was found to 
have an inhibitory effect on tumour cell invasion [18-20]. With regard to 
prostate tumors, apigenin was revealed to induce growth arrest of some prostate 
carcinoma cells [16, 21]. However, a systemic quantification of the effect of 
apigenin on prostate cancer cell proliferation, intercellular communication and 
cell motility has not yet been performed.  
A cellular model suitable for analyses of the effect of plant flavonoids on 
prostate carcinogenesis is the Dunning rat prostate carcinoma cell line MAT-
LyLu. In vitro, MAT-LyLu cells are characterized by relatively high levels of 
Cx43-mediated gap junctional coupling, and display relatively high “contact-
stimulated” motility, i.e. an induction of MAT-LyLu cell translocations is 
observed upon contact with neighboring cells [22]. Previously, a significant 
inhibition of cell motility in response to genistein, an isoconformer of apigenin, 
was observed [23]. Here, we systemically evaluated the effect of apigenin, 
administered at concentrations corresponding to those previously used to 
determine the effect of apigenin on basic cellular traits determining 
tumorigenesis [19, 24], on the cellular parameters relevant for prostate cancer 
development, i.e. cell proliferation, gap junctional intercellular coupling and 
motility.  
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MATERIALS AND METHODS 
 
Cell culture 
All the experiments were carried out on rat prostate cancer MAT-LyLu cells (the 
Dunning rat model) cultivated in Roswell Park Memorial Institute (RPMI) 1640 
medium (Sigma) supplemented with 5% foetal calf serum (Gibco) and 
antibiotics [22]. Stock cultures were harvested upon confluence with 0.25% 
trypsin, and seeded into culture dishes for endpoint experiments. Apigenin was 
administered to the cells from freshly made stock solution (4 mg/ml in DMSO). 
For the control experiments, DMSO (0.34% – an amount of solvent equivalent 
to 50 µM apigenin) was administered. 
 
Proliferation and toxicity assay 
Trypsinised MAT-LyLu cells were seeded into petri dishes (Nunclon, 35 mm) at 
an initial density of 7.5X103 cells/cm2. 24 hours after seeding, the culture 
medium was replaced with RPMI medium containing 25 or 50 µM apigenin,  
i.e. the concentrations corresponding to those used in previous studies on the 
biological activity of apigenin [19, 24], or a medium containing 0.34% DMSO. 
Cells were harvested 24, 48 and 72 hours after the administration of apigenin by 
trypsinisation, and the trypsin was subsequently inactivated with the original 
culture medium to preserve both the attached and suspended cells. Cell numbers 
were counted with a Bürker chamber. For the cytotoxicity tests, cells were 
cultured in control conditions or in the presence of 25 or 50 µM apigenin for  
24 hours, followed by the addition of Hoechst 33342 (Sigma) and propidium 
iodide (PI, Sigma, final dye concentrations: 1 μg/ml for Hoechst and 50 μM for 
PI) to the original culture medium. The relative numbers of necrotic 
(PI+Hoechst+) and living (PI-Hoechst+) MAT-LyLu cells were estimated using  
a Leica DM IRE2 microscope. The results from three independent experiments 
(N = 3) were taken for the estimation of means and SEM values. The statistical 
significance was assessed with a paired t-student test against the DMSO control.   
 
Estimation of gap junctional coupling and localisation of Cx43 
Gap junctional coupling was measured as described previously [25]. In short, 
monolayers of acceptor cells were cultured in the presence of 0.34% DMSO 
(control) or 25 or 50 µM apigenin for 24 hours, followed by the addition of 
calcein- and DiI-labelled donor cells plated at a ratio of l:50. After a 3 hour-long 
incubation, calcein transfer from the donor to recipient cells was evaluated using 
a Leica DM IRE2 microscope. Homologous gap junctional coupling was 
quantified as the number of recipient cells that obtained calecin from one donor 
cell (coupling ratio – cr). A dye transfer from at least 50 donor cells per coverslip 
was analysed in three independent experiments (N = 3) performed for each 
experimental condition. For the immunofluorescence studies, confluent cells on 
coverslips were fixed, stained with primary (mouse anti-Cx43 IgM, Sigma) and 
secondary antibodies (Cy3-conjugated goat anti-mouse IgM, Dianova) as 
described previously [26], and counterstained with bis-benzimide (Hoechst,  
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0.5 μg/ml). The abundance of Cx43-positive plaques in at least three 
independent specimens (N > 3) was semi-quantitatively assessed for each culture 
variant. The intensity of punctate Cx43-specific fluorescence was rated from (+) 
for immunoreactivity characteristic for the controls, to (+++) for a high 
abundance of Cx43-specific plaques.  
 
Immunoblotting analysis 
Monolayers of MAT-LyLu cells cultured in the presence of 0.34% DMSO 
(control) or 25 and 50 μM apigenin for 24 hours were washed, harvested using  
a cell scraper, centrifuged and dissolved in lysis buffer containing 50 mM Tris-
HCl (pH 7.4), 150 mM NaCl, 1% Triton X-100, 0.02% sodium azide and  
a proteinase inhibitor cocktail (20 μl/ml). The whole cell extract was then 
centrifuged and the protein content of the lysates was determined with the 
Bradford method. Cellular proteins (40 μg/lane) were applied to 12.5%  
SDS-polyacrylamide gels, followed by transfer to nitrocellulose. Blots were 
exposed to the primary antibody (rabbit anti-connexin43) and mouse monoclonal 
anti-actin antibody (both from Sigma) followed by detection of the antibodies 
using HRP-labeled secondary antibodies (Bio-Rad) and an ECL Western 
detection system (Pierce, Rockford, IL). 3 independent Western blot assays were 
performed. 
 
Time-lapse monitoring of cell movements 
MAT-LyLu cells were plated into culture flasks (Corning, 25 cm2) at initial cell 
densities chosen to compensate for the inhibitory action of apigenin on cell 
proliferation (200 to 400 cells/mm2). The movement of individual cells in the 
presence of DMSO or apigenin (25 and 50 µM) in RPMI medium with 
supplements was performed 24 hours after the administration of agents using  
a computer-assisted data acquisition system (recording time: 4 hours, with  
5-minute time intervals at 37ºC). The tracks of individual cells were determined 
from the series of changes in the cell centroid positions, and cell trajectories  
(> 50 cells, three independent experiments) were pooled and statistically 
analyzed [22, 27].  
 
RESULTS AND DISCUSSION 
 
Apigenin inhibits the proliferation of MAT-LyLu cells  
Apigenin was previously demonstrated to attenuate prostate carcinogenesis via 
the inhibition of cancer cell proliferation [21]. Therefore, we first concentrated 
on the effect of apigenin administered at the physiologically relevant 
concentrations of 25 and 50 μM [13, 24, 28] on the proliferation and motility of 
MAT-LyLu cells. An inhibition of MAT-LyLu cell mitotic activity was 
observed in the presence of apigenin. This was illustrated by the shapes of the 
growth curves drawn for the populations cultured in control conditions and in 
the presence of apigenin. While an exponential growth of MAT-LyLu cells was 
observed under the control conditions, a complete growth arrest was induced by 
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25 μM apigenin. Furthermore, a slight decrease in cell numbers in the presence 
of 50 μM apigenin could be seen, indicating a marginal cytotoxic effect exerted 
by apigenin at this concentration (Fig. 1A). In fact, cytotoxicity tests performed 
to discriminate between growth inhibition and the toxic effects of apigenin 
revealed a slight, but significant (p < 0.05) increase in the numbers of PI-positive 
(necrotic) cells in cultures incubated in the presence of 50 μM apigenin (7.6 ± 1.4%) 
compared to the DMSO control (1.6 ± 0.4%). On the other hand, no toxic effect 
of apigenin administered at the lower (25 μM) concentration on MAT-LyLu 
cells could be observed, since the fraction of dead cells (2.2 ± 0.4%) in the 25-μM 
apigenin-treated populations corresponded to control value.  
These observations are consistent with earlier data indicating that apigenin 
induces cell cycle arrest in normal and tumour cells. For example, the G1 and/or 
G2/M block of cell proliferation of normal and transformed cells has been 
described [12, 13, 29] to result from the activation of p53 and p21/WAF1 [12, 13], 
and their interference with the signalling pathways regulating the function of 
cyclins, such as those dependent on MAPK [21]. Thus, the interference of 
apigenin with MAT-LyLu cell growth indicates that the chemopreventive effect 
of this flavonoid on prostate carcinogenesis depends on its interference with 
cancer cell proliferation [10, 21].  
  
Apigenin augments the intensity of gap junctional coupling in MAT-LyLu 
cell populations 
Gap junctions are intercellular channels that enable the direct intercellular 
exchange of small metabolites. In the initial stages of tumour development, the 
inhibition of connexin expression and gap junctional coupling seems to promote 
tumour development in a coupling-dependent and/or -independent manner [7]. 
Since apigenin was previously shown to modulate the function of gap junctions 
[24, 28], we performed semi-quantitative analyses of the effect of apigenin on 
gap junctional coupling intensity in MAT-LyLu cell populations. A significant 
increase in the gap junction-mediated transfer of calcein was observed in cell 
populations cultured in the presence of 25 μM apigenin, compared to the control 
(Fig. 1B, see 1D cf. C). The cr value, which represents the averaged number of 
recipient cells that obtained calcein from one donor cell, increased from  
7.7, calculated for control variants, to 26.7 for populations cultivated in the 
presence of 25 μM apigenin (Fig. 1B).    
The effect of apigenin on coupling intensity was correlated with an increase in 
the numbers of “mature” Cx43-specific plaques at cell-to-cell interfaces 
observed in MAT-LyLu cell populations cultured in the presence of 25 and 50 μM 
apigenin (Fig. 1G, H cf. F, Tab. 1). On the other hand, Western blot analyses did 
not reveal any increase in the Cx43 protein levels induced by apigenin (Fig. 1I). 
Impaired intercellular communication via gap junctions is considered to 
facilitate the release of a potentially neoplasic cell from the controlling regime of 
the surrounding tissue, leading to tumour promotion [1]. Neoplastic cells usually 
display decreased levels of connexin expression  and/or gap junctional  coupling [7].  
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Fig. 1. The effect of apigenin on the proliferation of MAT-LyLu cells (A) and gap 
junctional coupling in MAT-LyLu cell populations (B). Apigenin inhibits the proliferation 
of MAT-LyLu cells in a dose-dependent manner as demonstrated by the growth curves 
(means ± SEM, A). This effect is correlated with an increased intensity of gap junctional 
coupling, illustrated by an increase in the cr parameter value, representing the number of 
calcein-positive recipient cells per one donor cell analysed 3 hours after donor cell seeding 
(B). C-E depict the spreading of calcein (green) from calcein/DiI (yellow-marked with x) 
loaded cells to acceptor cells in MAT-LyLu populations cultured in control (0.34% 
DMSO) conditions (C), and in the presence of 25 (D) and 50 μM (E) apigenin. This 
correlated with a higher abundance of gap junctional plaques at cell-to-cell interfaces in 
apigenin-treated (G, H) compared to control variants (F; for semi-quantitative analysis see 
Tab. 1). However, no significant effect of apigenin on Cx43 protein levels was observed 
(I). Bars represent means ± SEM. *p < 0.05 as determined by the paired-t-Student test 
obtained from three independent experiments (A), and from at least 50 donor cells per 
coverslip performed in triplicate (B). Scale bar = 20 μm.  
 
The data presented here, indicating that apigenin augments the intercellular 
transfer of metabolites in MAT-LyLu prostate carcinoma cell populations, 
suggests that this flavonoid may inhibit prostate carcinogenesis not only via 
proliferation arrest but also through an enhancement of intercellular 
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communication. A corresponding effect of apigenin on gap junctional coupling 
was described by Chaumontet et al. [24], who demonstrated that apigenin 
enhanced a dye transfer in populations of liver epithelial (REL) cells. Moreover, 
increased amounts of Cx43 were observed in apigenin-treated REL cells [24]. 
Our data indicates that apigenin enhances gap junctional coupling in MAT-LyLu 
populations without considerable effect on the Cx43 protein levels. Thus, the 
increased abundance of Cx43-positive plaques at cell-to-cell contacts in 
apigenin-treated cell populations indicates a shift in the proportion between the 
surface (active) and cytoplasmic pools of Cx43. 
 
Tab. 1. A semi-quantitative analysis of the effect of apigenin on the abundance of Cx43-
positive plaques in rat prostate MAT-LyLu cell populations (for details see the Materials 
and Methods section). 
 
 
 
 
 
(+) intermediate abundance (control); (++) high abundance; (+++) very high abundance 
 
On the other hand, the increase in the intensity of gap junctional coupling 
observed in MAT-LyLu cell populations incubated in the presence of 50 μM 
apigenin (Fig. 1E cf. C), although statistically significant when compared to the 
control, remains considerably lower than in variants treated with 25 μM apigenin 
(Fig. 1B). Since a marginal cytotoxic effect of 50 μM apigenin on MAT-LyLu 
cells was observed, it is conceivable that a partial closure of gap junctions may 
occur in sub-lethally affected cells at high apigenin concentrations to prevent a 
“by-stander” effect resulting from the intercellular spreading of erroneous signals 
via gap junctions. A modulation of the cytotoxicity of apigenin by a coupling 
status of cell populations was previously described for HeLa cells [28]. 
 
The motility of MAT-LyLu cells is reduced by treatment with apigenin 
According to the common model of carcinogenesis, a deregulation of pathways 
regulating cancer cell proliferation and gap junctional coupling is followed by 
the acquisition of the capability of unrestricted, invasive migration by cancer 
cells [3]. The induction of cell migration is a key step in cancer development, 
and a correlation between the motility of tumour cells and their invasive 
potential has been demonstrated [31]. It was previously shown that apigenin 
inhibits motility and reduces the invasive potential of HeLa Cx43 cells [19]. 
Therefore, we further concentrated on the effect of apigenin on the motility of 
MAT-LyLu cells. 
A morphological examination revealed that MAT-LyLu cells remained well 
attached and spread on the substrate in the presence of apigenin regardless of its 
concentration (Fig. 1), whereas time-lapse analyses revealed a high motile 
activity of MAT-LyLu cells under control conditions (Fig 2; Tab. 2). This is 
characteristic for these “contact-stimulated” cells when cultured at high densities [22]. 
Concentration of apigenin [μM] 0 25 50 
Intensity of punctate Cx43-specific fluorescence (+) (+++) (++) 
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Apigenin significantly inhibited MAT-LyLu motility in a dose-dependent 
manner as illustrated by circular diagrams depicting MAT-LyLu cell trajectories 
in control conditions (Fig. 2A) and in the presence of apigenin (Fig. 2B, C). 
Most importantly, the value of the length of cell displacement, calculated for 
cells cultured in the presence of 25 and 50 μM apigenin, respectively reached 
only 73 and 66% of the control (Fig. 2D; Tab. 2). 
 
 
Fig. 2. The effect of apigenin on the motility of MAT-LyLu cells. The trajectories of cells 
cultured in the presence of 0.34% DMSO (A), and 25 (B) and 50 μM (C) apigenin are 
depicted in the form of circular diagrams (axis scale in μm) drawn with the initial point of 
each trajectory placed at the origin of the plot. The quantification of the basic parameters of 
cell motility is presented (D). Apigenin significantly inhibits the speed of MAT-LyLu cell 
movement and displacement in a dose-dependent manner. *p < 0.001 determined with the 
Mann-Whitney test of the data obtained from three independent experiments (N = 3) 
performed against the DMSO control. 
 
While the cytostatic activity of apigenin was demonstrated in many normal and 
tumour cellular systems, only a few studies focused on its interference in cell 
motility, i.e. a factor determining tumour invasion [18, 19]. It was previously 
shown that human cervical carcinoma (HeLa Cx43) cells react to apigenin by 
inhibiting cell translocation, which correlates with impaired cell invasion [19]. 
Our results, which reveal that apigenin inhibits the motility of prostate 
carcinoma cells, suggest that this flavonoid may also interfere with prostate 
cancer cell invasion. Interestingly, a similar inhibition of MAT-LyLu cell 
motility was observed upon the administration of genistein [23]. 
In summary, this paper describes a novel experimental approach based on the in 
vitro quantification of the proliferation, migration and gap junctional coupling in 
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carcinoma cell populations as an efficient tool for the elucidation of the basic 
mechanisms of the chemopreventive action of flavonoids. We demonstrated that 
apigenin exerts a profound cytostatic effect on Dunning rat prostate carcinoma 
MAT-LyLu cells, which are an in vitro cellular model of prostate cancer  
[22, 32]. This effect is correlated with an augmentation of gap junction-mediated 
dye transfer in MAT-LyLu cell populations. As the disturbance of systems 
controlling cancer cell proliferation and the intensity of the transfer of small 
metabolites through gap junctions is crucial for the promotion of cancers 
including prostate carcinogenesis [7], the presented results indicate that apigenin 
may interfere with early prostate cancer cells via a combined action on cell 
proliferation and gap junctional coupling. On the other hand, the inhibition of 
MAT-LyLu cell motility observed upon apigenin treatment demonstrates that 
this flavonoid also seems to interfere with cellular invasive potential [32].  
 
Tab. 2. A summary of the quantitative data showing the effect of apigenin on the motility 
of MAT-LyLu cells.  
 
Parameters (means ± SEM) 
                Concentration of apigenin [μM] 
0 (DMSO) 25 50 
Total length of cell trajectory [μm]  178.3 ± 5.82 140.59 ± 7.85# 129.07 ± 5.19# 
Average speed of  cell movement [μm/h]1)  44.6 ± 1.46 36.15 ± 1.96# 32.27 ± 1.3# 
Total length of cell displacement [μm]  42.13 ± 4.37 27.69 ± 2.72# 24.9 ± 3.4# 
Average rate of cell displacement [μm/h] 2) 10.54 ± 1.1 6.92 ± 0.68# 6.23 ± 0.85# 
Coefficient of movement efficiency [CME]3) 0.23 ± 0.018 0.20 ± 0.017 0.17 ± 0.036 
 
The tracks of individual cells were determined from the series of changes in the cell centroid 
positions, and cell trajectories (> 50 cells, three independent experiments) were pooled and analyzed. 
1)Average speed of cell locomotion is defined as total length of cell trajectory/time of recording (4 h).  
2)Average rate of cell displacement is defined as total length of cell displacement from the starting 
point to the final cell position/time of recording (4 h). 3)Ratio of cell displacement to cell trajectory 
length. CME would equal 1 for a cell moving persistently along one straight line in one direction and 
0 for a randomly moving cell. Statistically significant (Mann-Whitney test) probe vs. control without 
apigenin; #p < 0.001. 
 
Furthermore, an experimental design based on the systemic quantification of the 
cellular traits involved in prostate carcinogenesis seems suitable for the 
elucidation of mutual interrelations between cellular traits decisive for 
carcinogenesis. In particular, we demonstrate that apigenin enhances gap 
junctional coupling in MAT-LyLu populations without considerable effect on 
the Cx43 protein levels. As gap junctional coupling depends on the stability of 
cell-to-cell contacts, the observed inhibition of intercellular translocations by 
apigenin (Fig. 2) may result in the stabilization of gap junctional plaques  
(Fig. 1F-H), which facilitates gap junctional intercellular coupling in prostate 
carcinoma cell populations (Fig. 1C-E). Research aimed at the elucidation of the 
effect of cell motility on the intensity of intercellular communication in MAT-LyLu 
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cell populations is now under way to verify this hypothesis. It is now  
a matter of debate whether this correlation might be of special importance as  
a tumour stage-specific function of gap junctions. Gap junctional coupling, 
while inhibiting cancer cell promotion, was also suggested to alleviate tumour 
invasion in some cellular models (for review see [7]). Therefore, further 
systemic evaluation of the effect of flavonoids on gap junctional coupling during 
prostate cancer promotion and progression is necessary for a better 
understanding of the mechanisms governing the postulated chemopreventive 
activity of these agents.  
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